Growth Metrics

Volitionrx (VNRX) Net Cash Flow Growth (3y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn 28.46%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 28.46%
Sep 30, 2025 -69.37%
Jun 30, 2025 54.84%
Mar 31, 2025 -29.98%
Dec 31, 2024 -11.02%
Sep 30, 2024 26.33%
Jun 30, 2024 -4.96%
Mar 31, 2024 -38.15%
Dec 31, 2023 99.73%
Sep 30, 2023 -329.06%
Jun 30, 2023 1.08%
Mar 31, 2023 46.89%
Dec 31, 2022 -35.05%
Sep 30, 2022 -36.16%
Jun 30, 2022 -72.95%
Mar 31, 2022 4.80%
Dec 31, 2021 7.80%
Sep 30, 2021 -46.12%
Jun 30, 2021 -26.18%
Mar 31, 2021 48.30%
Dec 31, 2020 23.77%
Sep 30, 2020 26.92%
Jun 30, 2020 87.80%
Mar 31, 2020 -18.02%
Dec 31, 2019 -30.83%
Sep 30, 2019 33.90%
Jun 30, 2019 43.67%
Mar 31, 2019 -36.72%
Dec 31, 2018 -49.76%
Sep 30, 2018 56.01%
Jun 30, 2018 -13.04%
Mar 31, 2018 -22.48%
Dec 31, 2017 -141.95%
Sep 30, 2017 -83.75%
Jun 30, 2017 -27.34%
Mar 31, 2017 -54.57%
Dec 31, 2016 182.97%
Sep 30, 2016 -90.04%
Jun 30, 2016 -105.96%
Mar 31, 2016 565.27%
Dec 31, 2015 -165.04%
Sep 30, 2015 -245.75%
Jun 30, 2015 -122.67%
Mar 31, 2015 321.30%
Dec 31, 2014 24.60%
Sep 30, 2014 -3.29%
Jun 30, 2014 -50.60%
Mar 31, 2014 55.52%